P&G Hygiene and Healthcare (PGHH) is a 69% subsidiary of the FMCG major - P&G, US. The two-product company is dominating both segments backed by strong brands, namely 'Vicks' in the anti-cold segment and 'Whisper' in feminine care segment (40% market... More
Archies Ltd. dominates the greeting cards business with a 50% market share in the organized sector. The company's greatest strength is its retail reach. The company has 475 plus franchise stores and around 40 owned stores. Apart from greeting cards, ... More
P&G HYGIENE | ARCHIES | P&G HYGIENE/ ARCHIES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 66.6 | -4.2 | - | View Chart |
P/BV | x | 45.5 | 0.4 | 12,651.9% | View Chart |
Dividend Yield | % | 0.4 | 0.0 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
P&G HYGIENE Jun-18 |
ARCHIES Mar-19 |
P&G HYGIENE/ ARCHIES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 10,360 | 47 | 22,279.6% | |
Low | Rs | 7,891 | 21 | 38,492.7% | |
Sales per share (Unadj.) | Rs | 756.4 | 47.0 | 1,609.6% | |
Earnings per share (Unadj.) | Rs | 115.4 | 0.2 | 53,400.4% | |
Cash flow per share (Unadj.) | Rs | 131.5 | 1.3 | 10,309.1% | |
Dividends per share (Unadj.) | Rs | 40.00 | 0 | - | |
Dividend yield (eoy) | % | 0.4 | 0 | - | |
Book value per share (Unadj.) | Rs | 248.2 | 34.9 | 710.3% | |
Shares outstanding (eoy) | m | 32.46 | 33.78 | 96.1% | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 12.1 | 0.7 | 1,692.4% | |
Avg P/E ratio | x | 79.1 | 155.0 | 51.0% | |
P/CF ratio (eoy) | x | 69.4 | 26.3 | 264.2% | |
Price / Book Value ratio | x | 36.8 | 1.0 | 3,834.9% | |
Dividend payout | % | 34.7 | 0 | - | |
Avg Mkt Cap | Rs m | 296,214 | 1,132 | 26,175.8% | |
No. of employees | `000 | 0.4 | 1.3 | 28.1% | |
Total wages/salary | Rs m | 1,152 | 319 | 361.2% | |
Avg. sales/employee | Rs Th | 68,392.5 | 1,242.2 | 5,505.9% | |
Avg. wages/employee | Rs Th | 3,209.7 | 249.6 | 1,285.9% | |
Avg. net profit/employee | Rs Th | 10,434.3 | 5.7 | 182,671.0% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 24,553 | 1,587 | 1,546.7% | |
Other income | Rs m | 241 | 26 | 918.7% | |
Total revenues | Rs m | 24,794 | 1,614 | 1,536.5% | |
Gross profit | Rs m | 6,154 | 44 | 14,018.0% | |
Depreciation | Rs m | 524 | 36 | 1,462.8% | |
Interest | Rs m | 53 | 27 | 197.0% | |
Profit before tax | Rs m | 5,818 | 7 | 79,694.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 2,072 | 0 | - | |
Profit after tax | Rs m | 3,746 | 7 | 51,313.7% | |
Gross profit margin | % | 25.1 | 2.8 | 906.3% | |
Effective tax rate | % | 35.6 | 0 | - | |
Net profit margin | % | 15.3 | 0.5 | 3,317.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 8,600 | 812 | 1,059.4% | |
Current liabilities | Rs m | 5,711 | 352 | 1,620.3% | |
Net working cap to sales | % | 11.8 | 28.9 | 40.7% | |
Current ratio | x | 1.5 | 2.3 | 65.4% | |
Inventory Days | Days | 18 | 117 | 15.7% | |
Debtors Days | Days | 22 | 44 | 50.3% | |
Net fixed assets | Rs m | 2,716 | 755 | 359.5% | |
Share capital | Rs m | 325 | 68 | 480.2% | |
"Free" reserves | Rs m | 7,730 | 1,113 | 694.9% | |
Net worth | Rs m | 8,055 | 1,180 | 682.6% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 14,254 | 1,685 | 846.0% | |
Interest coverage | x | 110.4 | 1.3 | 8,686.9% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.7 | 0.9 | 182.8% | |
Return on assets | % | 26.7 | 2.0 | 1,309.2% | |
Return on equity | % | 46.5 | 0.6 | 7,517.7% | |
Return on capital | % | 72.9 | 2.9 | 2,507.6% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 264 | 17 | 1,508.3% | |
Fx outflow | Rs m | 5,600 | 207 | 2,701.0% | |
Net fx | Rs m | -5,336 | -190 | 2,810.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 4,155 | 72 | 5,754.4% | |
From Investments | Rs m | -195 | -46 | 426.8% | |
From Financial Activity | Rs m | -1,061 | -18 | 5,927.4% | |
Net Cashflow | Rs m | 2,899 | 9 | 33,710.5% |
Indian Promoters | % | 1.9 | 60.6 | 3.1% | |
Foreign collaborators | % | 68.7 | 0.0 | - | |
Indian inst/Mut Fund | % | 12.3 | 0.7 | 1,757.1% | |
FIIs | % | 2.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 14.7 | 38.8 | 37.9% | |
Shareholders | 22,617 | 15,057 | 150.2% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare P&G HYGIENE With: RELAXO FOOTWEARS K.S.OILS JYOTHY LABS KARUTURI GLOBAL GILLETTE INDIA
Compare P&G HYGIENE With: P&G (US) UNILEVER PLC. (UK) HYPERMARCAS (Brazil)
The market scaled new life-time highs this week but it was the bears who took control. The benchmark indices, Sensex and Nifty ended mostly flat for the week but the momentum was in favour of the bears.
For the quarter ended September 2020, P&G HYGIENE has posted a net profit of Rs 3 bn (up 85.5% YoY). Sales on the other hand came in at Rs 10 bn (up 18.5% YoY). Read on for a complete analysis of P&G HYGIENE's quarterly results.
For the quarter ended December 2019, P&G HYGIENE has posted a net profit of Rs 1 bn (up 9.5% YoY). Sales on the other hand came in at Rs 9 bn (up 5.0% YoY). Read on for a complete analysis of P&G HYGIENE's quarterly results.
For the quarter ended September 2019, P&G HYGIENE has posted a net profit of Rs 1 bn (down 5.0% YoY). Sales on the other hand came in at Rs 9 bn (up 7.6% YoY). Read on for a complete analysis of P&G HYGIENE's quarterly results.
Here's an analysis of the annual report of ARCHIES LTD for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ARCHIES LTD. Also includes updates on the valuation of ARCHIES LTD.
For the quarter ended June 2019, ARCHIES LTD has posted a net profit of Rs 23 m (down 392.1% YoY). Sales on the other hand came in at Rs 313 m (down 8.6% YoY). Read on for a complete analysis of ARCHIES LTD's quarterly results.
More Views on NewsWere you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Our ace stock picker is ready to capitalise on a big growth opportunity.
The pandemic failed to thwart Richa's investing success formula for 2020.
More